Patient Voice Strengthened in New Drug Approval Process
This act ensures that patient experiences and opinions are given more weight when new drugs are approved. This means pharmaceutical companies must consider patient data, such as preferences or reported outcomes, potentially leading to safer and more effective treatments available to the public.
Key points
Drug companies must now consider patient data (e.g., experiences, preferences) when assessing the risks and benefits of new drugs.
Patient information will officially be part of the drug approval process, potentially influencing which drugs reach the market and how they are evaluated.
Expired
Citizen Poll